[Clinical aspects and follow-up in dilated cardiomyopathy].
Dilative cardiomyopathy is a heterogeneous myocardial disease characterized by a depressed contractile function and ventricular dilation. The exercise intolerance of patients with dilative cardiomyopathy is partly explained by changes of metabolism and composition of skeletal muscle, whereas the physical findings result from progressive heart failure and cardiac remodeling. The clinical course of the disease is highly variable and prognostic indicators of progressive heart failure or cardiac arrhythmias are of little value in the assessment of cardiac risk in an individual patient. During recent years the mortality of patients with dilative cardiomyopathy was 5-15%, which appears to be lower than previously reported. The differences in mortality today and in previous years may be explained by a more precise and earlier diagnosis of the disease and possibly better treatment strategies. Patients with a severely depressed left ventricular function but a stable clinical course, a good hemodynamic response to therapy, and an oxygen uptake of > 12 ml/kg min can be followed without heart transplantation. It can be expected that the definition of the molecular causes of dilative cardiomyopathy will lead to a better classification of the patients and the development of more efficient treatment strategies.
Grünig
E
E
Innere Medizin III, Heidelberg.
Brown
B
B
Franz
W
W
Zehelein
J
J
Rottbauer
W
W
Frey
N
N
Scheffold
T
T
Katus
H A
HA
D002311:Cardiomyopathy, Dilated / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology; D016189:Dystrophin / Q000235:genetics; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D009200:Myocardial Contraction / Q000502:physiology; D010375:Pedigree; D012307:Risk Factors
D016189:Dystrophin